Amgen (AMGN) Raw Materials (2013 - 2017)

Amgen's Raw Materials history runs 5 years deep, the most recent figure standing at $237.0 million for Q2 2017.

• In Q2 2017, Raw Materials changed N/A year-over-year to $237.0 million; the TTM figure through Jun 2017 stood at $237.0 million (changed N/A YoY), while the FY2016 annual figure was $225.0 million, up 11.94% from the prior year.
• Raw Materials was $237.0 million for Q2 2017 at Amgen, up from $216.0 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $237.0 million in Q2 2017 to a low of $198.0 million in Q4 2014.
• Historically, Raw Materials has averaged $214.4 million across 5 years, with a median of $216.5 million in 2013.
• The sharpest annual moves came in 2014 and 2016: Raw Materials decreased 8.76% in 2014, then increased 11.94% in 2016.
• A 5-year view of Raw Materials shows it stood at $217.0 million in 2013, then dropped by 8.76% to $198.0 million in 2014, then advanced by 1.52% to $201.0 million in 2015, then grew by 11.94% to $225.0 million in 2016, then rose by 5.33% to $237.0 million in 2017.
• The last three Raw Materials figures came in at $237.0 million (Q2 2017), $216.0 million (Q1 2017), and $225.0 million (Q4 2016), per Business Quant data.